Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision updated to v3.4.3. Previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded a publication entry for the 2024 article Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers and removed the Erratum entry for that article.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices for v3.4.1 and the government funding lapse message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide funding-status notice was added, and the Publications section was updated to include an Erratum for the Cancer Discovery article and a new citation, replacing the prior reference.SummaryDifference0.4%

- Check49 days agoChange DetectedAdds a glossary display and new metadata labels for 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus a site revision note 'Revision: v3.4.0'. Removes or revises prior items such as 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and the older revision 'v3.3.4'.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded a new Locations section listing study sites in CA, FL, MD, MA, NY, OH, TN, TX, UT, and VA (v3.3.3). Removed the older v3.3.2 location subsections and the HHS Vulnerability Disclosure link.SummaryDifference1%

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.